Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin

• Joan Comenge ,

  Contributed equally to this work with: Joan Comenge, Carmen Sotelo

  Affiliations Catalan Institute of Nanotechnology (ICN), Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain, International Iberian Nanotechnology Laboratory (INL), Braga, Portugal

  ⨯
• Carmen Sotelo ,

  Contributed equally to this work with: Joan Comenge, Carmen Sotelo

  Affiliation Department of Physiology, Faculty of Medicine, Santiago de Compostela University, Santiago de Compostela, Spain

  ⨯
• Francisco Romero,

  Affiliation Molecular Science Institute, University of Valencia, Paterna, Spain

  ⨯
• Oscar Gallego,

  Affiliation Oncology Department, Sant Pau Hospital, Barcelona, Spain

  ⨯
• Agustí Barnadas,

  Affiliation Oncology Department, Sant Pau Hospital, Barcelona, Spain

  ⨯
• Tomás García-Caballero Parada,

  Affiliation Department of Morphological Sciences, School of Medicine-University, Clinical Hospital, Santiago de Compostela University, Santiago de Compostela, Spain

  ⨯
• Fernando Domínguez ,

  * E-mail: fernando.dominguez@usc.es (FD); victor.puntes@icn.cat (VP)

  Affiliation Department of Physiology, Faculty of Medicine, Santiago de Compostela University, Santiago de Compostela, Spain

  ⨯
• Víctor F. Puntes

  * E-mail: fernando.dominguez@usc.es (FD); victor.puntes@icn.cat (VP)

  Affiliations Catalan Institute of Nanotechnology (ICN), Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain, Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

  ⨯